<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/215C8CB9-38B2-495F-89F4-21D4414B80C6"><gtr:id>215C8CB9-38B2-495F-89F4-21D4414B80C6</gtr:id><gtr:name>University of California, Berkeley</gtr:name><gtr:address><gtr:line1>University of California, Berkeley</gtr:line1><gtr:line2>191 University Hall</gtr:line2><gtr:postCode>CA 94720</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Human Genetics</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/215C8CB9-38B2-495F-89F4-21D4414B80C6"><gtr:id>215C8CB9-38B2-495F-89F4-21D4414B80C6</gtr:id><gtr:name>University of California, Berkeley</gtr:name><gtr:address><gtr:line1>University of California, Berkeley</gtr:line1><gtr:line2>191 University Hall</gtr:line2><gtr:postCode>CA 94720</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/92026CB9-1C58-4708-8AAC-2256F326499B"><gtr:id>92026CB9-1C58-4708-8AAC-2256F326499B</gtr:id><gtr:firstName>Maya</gtr:firstName><gtr:surname>Sieber-Blum</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802547"><gtr:id>C1738B5C-9AD5-4724-9416-C9BC4FCDF195</gtr:id><gtr:title>Human Epidermal Neural Crest Stem Cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802547</gtr:grantReference><gtr:abstractText>Stem cell biology is a promising new area of research that is likely to lead to new treatments for many debilitating diseases. There exist different types of stem cell, embryonic stem cells and adult stem cells. This application deals with a novel type of adult stem cell. Adult stem cells are safe because they do not form tumours when transplanted into the body and they do not raise ethical concerns. Adult stem cells have been used in medical practice for many years. A prime example are blood stem cells that are used to treat leukaemia. The adult stem cells on which this application focuses are named epidermal neural crest stem cells (EPI-NCSC) according to their origin and their location. They originate from an embryonic tissue, the neural crest, and they persist after birth in the epidermis of the hair follicle. The neural crest is an embryonic tissue that forms many vital tissues in our bodies. Some examples include bone of the face and skull; the teeth; all nerve cells outside the brain and spinal cord; neurons sensing pain, touch, and temperature; muscle cells of the top part of the heart and their connecting large blood vessels. The Sieber-Blum group and colleagues have discovered and characterized EPI-NCSC in the mouse and found, among other results, that they can give rise to all neural crest derivatives, including bone/cartilage cells, nerve cells, nerve supporting cells, and muscle cells. The most exciting result was that mouse EPI-NCSC implanted into the injured mouse spinal cord caused improvement in sensing touch. The current grant application deals for the first time with EPI-NCSC from humans. It has 5 aims; (1) developing techniques to amplify the cell numbers into millions of stem cells in the culture plate; (2) making sure that there are no chromosome breaks while the cells grow in culture; (3) separating EPI-NCSC from cells that already might have started to develop; (4) confirming that human EPI-NCSC do not form tumors when implanted into the body; (5) create bone cells within a three-dimensional scaffold and identify markers that characterize the bone cells. After all five aims are fulfilled, expectations are that the manufactured bone cells are ready for pre-clinical testing in animal models. There is a high demand for bone in regenerative medicine with an annual market opportunity of 155 billion dollar for dental/cranial regeneration and orthopaedic biomaterials.</gtr:abstractText><gtr:technicalSummary>The proposed work addresses hurdles that need to be overcome in order to use human epidermal neural crest stem cells (hEPI-NCSC) in clinical applications. The current application focuses on bone engineering. There are 5 aims, (1) expand hEPI-NCSC in vitro, (2) test effect of expansion on karyotype, (3) purify multipotent subset of hEPI-NCSC (4) test tumorigenicity in vivo, and (5) define biomarkers for osteogenic hEPI-NCSC in a 3D scaffold model. Sieber-Blum and colleagues have discovered EPI-NCSC in the mouse hair follicle. EPI-NCSC are remnants of the embryonic neural crest in a postnatal location, the bulge of the hair follicle. The neural crest is a transient tissue of the vertebrate embryo that gives rise to a diverse array of cells and tissues in the adult organism. Some examples of neural crest derivatives include craniofacial bone and cartilage, tooth papillae, the autonomic and enteric nervous systems, primary sensory neurons, and musculature of the cardiac outflow tract and great vessels. Mouse EPI-NCSC (mEPI-NCSC) are multipotent stem cells that are able to undergo self-renewal and to differentiate into all neural crest-derived cell types. They can be expanded in vitro into millions of stem cells without losing stem cell markers, and they are distinctly different from other known skin-resident stem cell/progenitors. In a mouse spinal cord injury model mEPI-NCSC showed several desirable features, including absence of tumorigenicity, differentiation into neurons and oligodendrocytes, and improvement of sensory function. The Sieber-Blum group has now identified and characterized hEPI-NCSC. At least a major subset of cells consists of multipotent cells. Furthermore, hEPI-NCSC express the neural crest stem cell signature genes as well as other neural crest-characteristic genes, including SNAI2, SOX10, MSX1 and TNFRSF1B (p75NTR) and the iPS genes, MYC, SOX2, KLF4, and LIN28, whereas Nanog and Oct-4 are barely detectable or absent, respectively. As multipotent embryonic remnants in an adult location, EPI-NCSC are attractive candidates for future cell replacement therapy/regenerative medicine. They are easily accessible by minimal invasive procedure, which does not cause any ethical concerns. By virtue of their migratory ability, EPI-NCSC can be isolated as a highly pure population of multipotent stem cells. As the patients own stem cells could be isolated, hEPI-NCSC are conducive to autologous transplantation, which would avoid graft rejection. Finally, there is a high demand and marketing opportunity for dental and craniofacial regeneration and orthopaedic biomaterials.</gtr:technicalSummary><gtr:fund><gtr:end>2012-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>406361</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Modeliing autims using hEPI-NCSC</gtr:description><gtr:id>CE73DE59-C4D0-4B66-ABAF-631E1DBDBAB6</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>rRZzLcoUwQh-1</gtr:outcomeId><gtr:piContribution>fellowship obtained; collaboration established</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Reprogram hEPI-NCSC into iPS cells</gtr:description><gtr:id>8CB3D420-9BB6-469B-B134-460B57194A0D</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>tcK8v1zQRvB-1</gtr:outcomeId><gtr:partnerContribution>grant application</gtr:partnerContribution><gtr:piContribution>grant application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Medicine</gtr:department><gtr:description>hEPI-NCSC in animal models of Parkinson's disease</gtr:description><gtr:id>1155D308-4759-4458-912E-670B74C61F4F</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>nu9Yh3UGQzj-1</gtr:outcomeId><gtr:partnerContribution>preliminary data, grant application</gtr:partnerContribution><gtr:piContribution>Together with Dr Roger Barker, we have submitted a grant application to test hEPI-NCSC and dopaminergic neurons derived thereof in rat models of acute and chronic PD.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Efficacy of hEPI-NCSC in dog clinical trial</gtr:description><gtr:id>B5B123DF-A202-4DDE-A9AD-32EFC642C93C</gtr:id><gtr:impact>preliminary dat, pre-application</gtr:impact><gtr:outcomeId>sRWMUdYuLPp-1</gtr:outcomeId><gtr:partnerContribution>pre-application to CIRM</gtr:partnerContribution><gtr:piContribution>preliminary data, grant application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Modeling sensory neuropathies</gtr:description><gtr:id>25E19563-5751-4042-8153-124CCB167289</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>ka4RAx1cZPH-1</gtr:outcomeId><gtr:partnerContribution>Preliminary data, grant application</gtr:partnerContribution><gtr:piContribution>together with Dr David Bennett, KCL, we have submitted a grant application for generating hEPI-NCSC from patients with mutations that lead to peripheral neuropathies. This collaboration is aimed at generating a better system to model peripheral neuropathies and to establish high through-put drug screens.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>34000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovation Grant</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>289378A9-C090-472C-92B5-F75DD755037F</gtr:id><gtr:outcomeId>dncmZs4aTqT0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>landmark patent thata covers proces and stem cells; epdiermal neural crest stem cells (|EPI-NCSC)

The present invention describes novel methods for isolating a substantially pure cell population of non-embryonic epidermal neural crest stem cells from the bulge-region of mammalian hair follicles. Also disclosed is the substantially pure cell population of follicular bulge-derived neural crest stem cells for medical research and therapeutic use.</gtr:description><gtr:grantRef>G0802547</gtr:grantRef><gtr:id>F0A93B5F-1777-487D-94A4-48708D027067</gtr:id><gtr:impact>Licensing in progress</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>DX2DrF8pWya</gtr:outcomeId><gtr:patentId>US8030072</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Method of isolating epidermal neural crest stem cells (Patent)</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Differentiation of hEPI-NCSC into dopaminergic neurons.</gtr:description><gtr:grantRef>G0802547</gtr:grantRef><gtr:id>F41B7FA5-A90D-4524-9094-362BD21B5F9B</gtr:id><gtr:impact>N/A</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>523A1908FA7</gtr:outcomeId><gtr:protection>Copyrighted (e.g. software)</gtr:protection><gtr:title>human epidermal neural crest stem cells (copyright)</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Parkinson's UK</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>084361B1-BFBB-47A0-ABCC-5C7619CD131A</gtr:id><gtr:impact>Stem Cell Research Policy at Parkinson's UK</gtr:impact><gtr:outcomeId>hnSEfHf25k3</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed technologies to culture human epidermal neural crest stem cells (hEPI-NCSC) from hair follicles. We have shown that the cells are multipotetn stem cells. We can expand the cells ex vivo into millions of stem cells. We can differentiate them into dopaminergic neurons and into melanocytes.</gtr:description><gtr:id>61B5D5FD-C55D-4E1C-A408-5AD300ECE481</gtr:id><gtr:impact>This is a novel type of multipotent adult stem cell, which is suitable for future applications in cell-based therapy and regenerative medicine.</gtr:impact><gtr:outcomeId>DD45BFD66A0</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>hEPI-NCSC</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2483F699-5C35-4CAA-82D2-3E3CF1468B9C</gtr:id><gtr:title>Differentiation of human epidermal neural crest stem cells (hEPI-NCSC) into virtually homogenous populations of dopaminergic neurons.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fe203291ac86eb562f2e19f075c83a0"><gtr:id>1fe203291ac86eb562f2e19f075c83a0</gtr:id><gtr:otherNames>Narytnyk A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>pm_15265_25_24399192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57DCE4A5-543F-4BE9-83BB-4852A9B65F4B</gtr:id><gtr:title>Epidermal stem cell dynamics.</gtr:title><gtr:parentPublicationTitle>Stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/966f396421576f9a9acfbf3daa69be7b"><gtr:id>966f396421576f9a9acfbf3daa69be7b</gtr:id><gtr:otherNames>Sieber-Blum M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-6512</gtr:issn><gtr:outcomeId>agL2bibkwu6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2036CCB4-A041-4E77-B107-C28EE8D0274E</gtr:id><gtr:title>Diffusion heterogeneity tensor MRI (?-Dti): mathematics and initial applications in spinal cord regeneration after trauma - biomed 2009.</gtr:title><gtr:parentPublicationTitle>Biomedical sciences instrumentation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24e4b186a342f0d5785e0a9a03d0800c"><gtr:id>24e4b186a342f0d5785e0a9a03d0800c</gtr:id><gtr:otherNames>Ellington BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0067-8856</gtr:issn><gtr:outcomeId>6795ABD8900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>457A8B1C-1971-4B0A-AB7C-4E97BEF3498A</gtr:id><gtr:title>Epidermal neural crest stem cells (EPI-NCSC) and pluripotency.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/966f396421576f9a9acfbf3daa69be7b"><gtr:id>966f396421576f9a9acfbf3daa69be7b</gtr:id><gtr:otherNames>Sieber-Blum M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>B05D23B0787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>716E91F7-3479-4DB4-8333-98E751A0AFD2</gtr:id><gtr:title>Human epidermal neural crest stem cells (hEPI-NCSC)--characterization and directed differentiation into osteocytes and melanocytes.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f12f9a655a1f757ebf37617d9c24e56"><gtr:id>4f12f9a655a1f757ebf37617d9c24e56</gtr:id><gtr:otherNames>Clewes O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>HDzftrH7WZX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C212E18-E06E-4F07-97E0-D1540308E701</gtr:id><gtr:title>Neural Crest Stem Cells - Breakthroughs and applications</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d50adaa9129e3766164bed928cffeb42"><gtr:id>d50adaa9129e3766164bed928cffeb42</gtr:id><gtr:otherNames>Sieber-Blum, Maya</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-981-4343-80-0</gtr:isbn><gtr:outcomeId>bcKxj6kfaSV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A5D73BD-2E9B-47AF-9143-B6520F210BB6</gtr:id><gtr:title>Human epidermal neural crest stem cells as candidates for cell-based therapies, disease modeling, and drug discovery.</gtr:title><gtr:parentPublicationTitle>Birth defects research. Part C, Embryo today : reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/966f396421576f9a9acfbf3daa69be7b"><gtr:id>966f396421576f9a9acfbf3daa69be7b</gtr:id><gtr:otherNames>Sieber-Blum M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1542-975X</gtr:issn><gtr:outcomeId>544a28ed3e3766.80743244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F823574-F5F3-4E1C-8024-A6CFBA4E6922</gtr:id><gtr:title>Human epidermal neural crest stem cells as a source of Schwann cells.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04707e0f2a7b22b18ba34659cbe7c525"><gtr:id>04707e0f2a7b22b18ba34659cbe7c525</gtr:id><gtr:otherNames>Sakaue M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>5675e9e80614e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A3152CF-D530-4CD6-B739-D9474E22EDF1</gtr:id><gtr:title>Characterization of epidermal neural crest stem cell (EPI-NCSC) grafts in the lesioned spinal cord.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/966f396421576f9a9acfbf3daa69be7b"><gtr:id>966f396421576f9a9acfbf3daa69be7b</gtr:id><gtr:otherNames>Sieber-Blum M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>F14D9EFBE0D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>917E9F1D-A4E6-4C67-8347-56DEF405C722</gtr:id><gtr:title>Epidermal neural crest stem cells and their use in mouse models of spinal cord injury.</gtr:title><gtr:parentPublicationTitle>Brain research bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/966f396421576f9a9acfbf3daa69be7b"><gtr:id>966f396421576f9a9acfbf3daa69be7b</gtr:id><gtr:otherNames>Sieber-Blum M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0361-9230</gtr:issn><gtr:outcomeId>fQfuyP5jHMu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94FEC0CB-643C-4FDD-8420-E53C29886921</gtr:id><gtr:title>Essential role of stem cell factor signaling in primary sensory neuron development.</gtr:title><gtr:parentPublicationTitle>Developmental neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e441f690ab504eed7b3f6edb5fd51fcd"><gtr:id>e441f690ab504eed7b3f6edb5fd51fcd</gtr:id><gtr:otherNames>Zhang ZJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0378-5866</gtr:issn><gtr:outcomeId>48553D21A73</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11EE4761-50F2-4C37-8B63-67AC34F70BE6</gtr:id><gtr:title>Mouse epidermal neural crest stem cell (EPI-NCSC) cultures.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/966f396421576f9a9acfbf3daa69be7b"><gtr:id>966f396421576f9a9acfbf3daa69be7b</gtr:id><gtr:otherNames>Sieber-Blum M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn><gtr:outcomeId>20D4F82D4D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F246520-3A6A-4DDB-A90B-2F3D071AE2D4</gtr:id><gtr:title>Norepinephrine transport-mediated gene expression in noradrenergic neurogenesis.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19dc33214127d03df0f2e6c444140e34"><gtr:id>19dc33214127d03df0f2e6c444140e34</gtr:id><gtr:otherNames>Hu YF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>E45BCD30EE7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69C4F19B-9419-4B4B-A153-BA0804137B80</gtr:id><gtr:title>An epidermal neural crest stem cell (EPI-NCSC) molecular signature.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19dc33214127d03df0f2e6c444140e34"><gtr:id>19dc33214127d03df0f2e6c444140e34</gtr:id><gtr:otherNames>Hu YF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>1E86684FDA4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15FE772A-1CE1-4F44-AC07-493AAED62747</gtr:id><gtr:title>Stem cells in canine spinal cord injury--promise for regenerative therapy in a large animal model of human disease.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b32a5114d9546f10f541ee3f2b2ac8d8"><gtr:id>b32a5114d9546f10f541ee3f2b2ac8d8</gtr:id><gtr:otherNames>McMahill BG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>544a283717b4b7.02427498</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D995E514-E5DD-4255-AA28-CF40E9BB64E8</gtr:id><gtr:title>Epidermal neural crest stem cell (EPI-NCSC)--mediated recovery of sensory function in a mouse model of spinal cord injury.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19dc33214127d03df0f2e6c444140e34"><gtr:id>19dc33214127d03df0f2e6c444140e34</gtr:id><gtr:otherNames>Hu YF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>KaE2x3tq7sE</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802547</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>